Cleanse Clinic, PLLC

Cleanse Clinic, PLLC was paid $6.88M by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 26% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	21,763	$1.69M
2019	27,242	$1.50M
2020	17,704	$953K
2021	15,993	$828K
2022	13,381	$808K
2023	10,482	$629K
2024incomplete	7,511	$477K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	26%	31,330	21,059	$1.77M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	22%	34,817	22,343	$1.52M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	20%	14,695	12,887	$1.39M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	14%	4,591	4,184	$956K
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	3.4%	7,490	5,974	$237K
T1007	Alcohol and/or substance abuse services, treatment plan development and/or modification	3.0%	3,716	3,431	$206K
T2023	Targeted case management; per month	2.3%	531	491	$159K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	2.2%	1,602	301	$154K
90853	Group psychotherapy (other than of a multiple-family group)	1.3%	7,413	5,625	$93K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	1.2%	460	428	$86K
90791	Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation	1.1%	1,279	1,098	$79K
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	1.1%	1,761	1,424	$76K

15 more codes

90837	Psychotherapy session, about an hour	<1%	901	$57K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	883	$26K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	124	$14K
90838		<1%	283	$14K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	196	$9K
H0049	Alcohol and/or drug screening	<1%	603	$7K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	215	$5K
81025		<1%	701	$5K
99354		<1%	72	$4K
99214	Doctor's office visit, returning patient (more involved)	<1%	45	$3K
99215	Doctor's office visit, returning patient (complex)	<1%	15	$1K
H0001	Alcohol and/or drug assessment	<1%	38	$1K
96127		<1%	284	$243.33
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	15	$127.40
90836		<1%	16	$87.39

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGROLL, MARGARET (BUSINESS MANAGER)